Vitamin D supports calcium balance and bone mineralisation. Testing is useful in selected circumstances, while excess can raise calcium and harm health.

Supplements - Vitamins & essentials

Vitamin D: deficiency, testing and excess

Last updated 1 October 2026. How we write this.

Vitamin D supports calcium balance and bone mineralisation. Testing is useful in selected circumstances, while excess can raise calcium and harm health.

Vitamin D helps the body absorb calcium and maintain properly mineralised bones. Deficiency can impair these functions, but testing is most useful when symptoms or particular risks make the result clinically meaningful. Correcting deficiency and taking large amounts without an indication are different decisions: excess vitamin D can raise blood calcium and cause harm.

What vitamin D is and where it comes from

Vitamin D is a fat-soluble nutrient that the body converts into a hormone-like signal. Skin makes it when exposed to ultraviolet B radiation from sunlight, and food supplies some. Sources include oily fish, egg yolks and fortified foods, although fortification varies between products and countries.

In the UK, sunlight is not strong enough for reliable skin production during autumn and winter. Production also depends on skin pigmentation, age, clothing and time spent outdoors. Sunlight through ordinary window glass is not an effective source because the glass blocks most ultraviolet B radiation.

UK government and NHS advice is that everyone, including pregnant and breastfeeding women, should consider taking a daily supplement containing 10 micrograms of vitamin D during autumn and winter. The NHS advises considering it all year for people who are not often outdoors, live in a care home, usually cover most of their skin outdoors, or have dark skin, for example people from African, African-Caribbean or south Asian backgrounds. Different advice applies to babies and young children; a health visitor, pharmacist or GP can explain it. This is public health advice rather than a personal recommendation, and the NHS notes that some medical conditions mean people may not be able to safely take as much.

This does not make tanning a useful health target. Skin damage and vitamin D production are separate consequences of ultraviolet exposure, and a tan cannot reveal vitamin D status. Food intake, seasonal changes and the body's stores also contribute to the blood level.

The mechanism: calcium, phosphate and bone

Vitamin D first undergoes conversion in the liver to 25-hydroxyvitamin D, the main circulating form used to assess status. The kidneys then help produce its active form. This binds to receptors inside cells and changes the activity of genes involved in mineral balance.

One major effect is to increase intestinal absorption of calcium and phosphate. These minerals help harden the protein framework of bone. Vitamin D is therefore necessary for normal bone mineralisation, but it is not the building material itself: calcium supply and other aspects of nutrition still matter.

When calcium absorption falls, parathyroid hormone helps defend blood calcium, partly by increasing calcium release from bone. This explains an important apparent contradiction: someone can have vitamin D deficiency while their blood calcium remains within the laboratory reference range. The body may be preserving blood chemistry at the expense of the skeleton.

Vitamin D receptors occur in many tissues, including immune cells. That makes wider biological effects plausible, but the presence of a receptor does not prove that additional vitamin D improves health once requirements are met.

Deficiency and who is more likely to develop it

Prolonged, substantial deficiency can cause rickets in growing children and osteomalacia in adults. Both involve inadequate mineralisation. Osteomalacia can cause bone pain and muscle weakness; it is different from osteoporosis, in which bone strength declines through changes in bone quantity and structure.

Risk reflects both supply and the body's ability to process it. Relevant circumstances include:

Limited outdoor exposure, including being housebound or living in residential care.
Covering most of the skin outdoors, or having darker skin in a setting with limited ultraviolet B exposure.
Conditions that reduce fat absorption, such as coeliac disease, or some forms of bowel surgery.
Kidney or liver disease, which can alter vitamin D handling and mineral balance.
Older age, when skin production and other contributors to nutritional status may change.

These factors indicate increased probability, not a diagnosis. Conversely, being active outdoors does not exclude deficiency. Fatigue and general aches are particularly poor diagnostic clues because they have many possible causes. Attributing them automatically to vitamin D can delay recognition of another explanation.

What testing can and cannot tell you

The usual blood test measures total 25-hydroxyvitamin D. It reflects vitamin D obtained from skin production, food and supplements over time. The active form is generally unsuitable for routine assessment because its concentration is tightly regulated and can remain normal, or even rise, during deficiency.

NICE advises against routine testing unless someone has symptoms of deficiency, is at particularly high risk, or has another clinical reason for testing. The useful question is whether knowing the result would change clinical decisions. A test marketed as a general wellness check does not automatically meet that standard.

Results require context. Season, laboratory methods and recent changes in intake can affect the measurement. Laboratories may report different units, so apparently different numbers may represent the same concentration. Definitions of borderline status also vary between professional bodies; a commercial 'optimal' range is not necessarily an established health target.

A blood result cannot by itself explain symptoms or measure bone strength. Depending on the circumstances, clinicians may consider calcium, kidney function and other findings alongside it. Repeated measurements without a clear clinical question can encourage people to chase small fluctuations that have no demonstrated benefit.

Evidence that deficiency matters does not establish that progressively higher vitamin D levels are better. Preventing a shortage and seeking benefits above adequate status are different research questions.

What the evidence actually shows

The evidence connecting substantial deficiency with impaired bone mineralisation is strong. It combines established physiology, characteristic clinical disease and evidence that restoring adequate vitamin D supports recovery of mineralisation. This is a firmer foundation than claims based only on a correlation between a blood result and a later illness.

For generally healthy adults who are not selected for deficiency, large randomised trials have not shown consistent fracture prevention from vitamin D alone. The large VITAL trial found no reduction in fractures in its study population. That result challenges blanket fracture-prevention claims, but it does not establish that addressing genuine deficiency is unimportant.

Population differences matter. Findings from independently living adults cannot simply be transferred to frail care-home residents with low calcium intake and low vitamin D status. Studies combining calcium and vitamin D also answer a different question from studies of vitamin D alone. An apparent benefit from the combination cannot establish the independent contribution of either component.

Observational studies link low vitamin D with several illnesses, but illness itself can reduce outdoor activity, appetite and nutritional status. These relationships can therefore run in both directions. Large trials have generally not confirmed broad claims that supplementation prevents cardiovascular disease or cancer incidence in otherwise unselected adults.

Claims about longer life or better athletic performance often extend beyond the evidence. Small trials may be informative, but short follow-up, varied starting levels and reliance on blood markers limit conclusions. A higher laboratory value is not equivalent to fewer fractures, better function or a longer life.

Why excess can be harmful

Vitamin D is fat-soluble, and excessive supplemental intake can have effects that persist. Too much can increase calcium absorption enough to produce hypercalcaemia, meaning abnormally high blood calcium. This can damage the kidneys and affect other organs. Megadoses are not a harmless shortcut to better status.

Potential warning symptoms include unusual thirst, frequent urination, nausea, vomiting, constipation and weakness. These are not specific enough to confirm toxicity without assessment. Ordinary sunlight exposure does not usually cause vitamin D toxicity because skin production is regulated, although ultraviolet exposure can still damage skin.

Overlapping products can obscure total intake: a multivitamin, a bone-health product and a separate vitamin D product may all contain it. Some trials of very large intermittent amounts have also reported more falls or fractures. The outcome depends on the regimen and population, but these findings directly challenge the assumption that more must be better.

Unusual thirst, frequent urination or persistent vomiting during supplement use should prompt someone to stop self-directed experimentation and contact a GP or NHS 111 promptly. Call 999 for collapse, unresponsiveness or another life-threatening emergency. Anyone taking prescribed vitamin D or living with a condition affecting calcium should seek guidance from their care team rather than change prescribed medicines independently.

Who needs a different interpretation

Children, pregnant people, people with malabsorption and those with kidney disease have circumstances that cannot be reduced to a general adult wellness target. In kidney disease, for example, the conversion to active vitamin D and the regulation of phosphate may both be disrupted. A standard vitamin D result captures only part of that picture.

For someone with osteoporosis or a previous fragility fracture, vitamin D is one part of a broader assessment. It does not replace consideration of bone strength, falls, nutrition and existing care. Some prescription medicines affect vitamin D or calcium balance, and raised calcium can make some heart medicines more harmful. Anyone taking regular medicines, or living with kidney disease, should check with a pharmacist or GP before adding a vitamin D product, including products that combine it with calcium.

How to judge a vitamin D claim

First ask who was studied and whether participants were deficient. Then ask what improved: a blood concentration, a symptom, physical function or a major health outcome. Check whether the study was randomised, how long it lasted and whether calcium or another intervention was included.

Be cautious when a claim turns an association into a cause, presents an unusually high blood target as universally desirable, or uses a cellular mechanism as proof of clinical benefit. Sound interpretation keeps three questions separate: whether deficiency is present, whether a test would be useful, and whether additional vitamin D has demonstrated benefits for people in comparable circumstances.

This lesson is general education, not medical advice. Seek qualified advice if you have symptoms or a medical condition, are pregnant, or take regular medicines.

Related in this classroom

Magnesium: forms, claims and interactions (8 min read)
Omega-3 and fish oil: what the evidence means (8 min read)
Do you need a multivitamin? (7 min read)
Creatine monohydrate: benefits, limits and safety (8 min read)

Related in other classrooms

Balance and preventing falls (Healthy Ageing & Longevity)

The studies behind this page

Vitamin D fact sheet for health professionals - NIH Office of Dietary Supplements

Sources for this classroom

Educational content only. Not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional before changing your health regimen.